Human Papillomavirus Infection with Multiple Types: Pattern of Coinfection and Risk of Cervical Disease

Quadrivalent Vaccine against Human Papillomavirus to Prevent High-Grade Cervical Lesions

New England Journal of Medicine · 2007 · 2K citations · Full text

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

Jorma Paavonen, Paulo Naud, Jorge Salmerón et al. · The Lancet · 2009 · 1.6K citations

As04-adjuvanted Vaccine, Gynecology, Oncogenic Hpv Types +16

Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial

Jorma Paavonen, David Jenkins, F. Xavier Bosch et al. · The Lancet · 2007 · 1.3K citations

Vaccination, Vaccine Safety, Interim Analysis +9

Genital Human Papillomavirus Infection: Incidence and Risk Factors in a Cohort of Female University Students

Rachel L. Winer · American Journal of Epidemiology · 2003 · 1.1K citations · Full text

The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus‐Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV‐Naive Women Aged 16–26 Years

Darron R. Brown, Susanne K. Kjær, Kristján Sigurðsson et al. · The Journal of Infectious Diseases · 2009 · 627 citations · Full text